Sorrento Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
21,911.30
34,657.00
50,074.00
63,937.00
11,109.00
212,526
Depreciation, Depletion & Amortization
1,290.40
3,184.00
2,370.00
2,885.00
7,079.00
9,054
Other Funds
1,000.00
-
2,000.00
-
1,012.00
91,824
Funds from Operations
16,927.60
28,542.00
56,871.00
96,434.00
81,579.00
117,767
Changes in Working Capital
438.00
222.00
14,802.00
25,542.00
17,601.00
6,000
Net Operating Cash Flow
16,489.60
28,764.00
42,069.00
70,892.00
99,180.00
111,767
Capital Expenditures
931.30
591.00
3,707.00
6,860.00
10,972.00
Sale of Fixed Assets & Businesses
-
-
27,808.00
-
-
Purchase/Sale of Investments
-
10,000.00
11,500.00
750.00
5,000.00
Net Investing Cash Flow
503.50
10,591.00
12,601.00
17,452.00
16,529.00
Issuance/Reduction of Debt, Net
6,850.00
7,500.00
3,095.00
38,869.00
3,241.00
Net Financing Cash Flow
43,568.50
79,590.00
3,396.00
131,740.00
53,675.00
Net Change in Cash
26,575.40
40,235.00
32,864.00
43,396.00
61,969.00
Free Cash Flow
16,909.90
29,355.00
45,776.00
77,752.00
110,152.00
Deferred Taxes & Investment Tax Credit
-
1,702.00
33,337.00
982.00
35,679.00
6,119
Net Assets from Acquisitions
-
-
-
9,842.00
557.00
Other Sources
427.80
-
-
-
-
Change in Capital Stock
37,718.50
72,090.00
1,699.00
92,871.00
57,928.00
Exchange Rate Effect
-
-
-
-
65.00
About Sorrento Therapeutics
View Profile
